Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Portugal hepatitis A outbreak: 'Far from controlled'

In a follow-up to the hepatitis A outbreak in Portugal, the Director General of Health reported the case tally has grown to 138 since the beginning of the year, according to an MSN Notocias report (computer translated). And the outbreak is considered from from being under control.

Published
10 April 2017
From
Outbreak News Today
WHO prequalifies first generic active ingredient for hepatitis C medicines

On 31 March 2017, WHO for the first time prequalified a generic active pharmaceutical ingredient (API) for hepatitis C – sofosbuvir. Sofosbuvir is an essential ingredient for new, highly effective medicines to treat hepatitis C called direct active antivirals (DAAs). The prequalified product’s manufacturer is Mylan Laboratories Ltd - India.

Published
05 April 2017
From
World Health Organization
Scale up of hepatitis C treatment possible as Brazil rejects patent on key drug

Treatment for hepatitis C using the key drug sofosbuvir could be vastly scaled up in Brazil after the decision by the National Agency of Health Surveillance (Anvisa) to reject a key patent application on the drug marketed by pharmaceutical corporation Gilead. The decision could pave the way to enable generic competition in Brazil, which should lead to price reductions, making it more affordable to scale up treatment.

Published
03 April 2017
From
MSF
France Reaches Agreement With Gilead To Drop Prices Of Hepatitis C Treatment

New prices are expected to come into effect on 1 April. For Sovaldi, it will drop from €41,000 euros to less than €28,700 euros for the treatment of hepatitis C.

Published
03 April 2017
From
Intellectual Property Watch
Portugal reports hepatitis A outbreak, most cases in Lisbon

The cases are predominately being seen in Greater Lisbon and many cases are affecting men who have sex with men (MSM).

Published
03 April 2017
From
Outbreak News Today
Co-infection with HCV increases cancer risk for people with HIV

People with HIV and hepatitis C virus (HCV) co-infection have an increased risk of non-AIDS-defining cancers compared to people with HIV mono-infection, investigators from Spain report in the

Published
31 March 2017
By
Michael Carter
New Report Lays Plan to Eliminate 90,000 Hepatitis B and C Deaths by 2030

Hepatitis B and C kill more than 20,000 people every year in the United States. A new report from the National Academies of Sciences, Engineering, and Medicine presents a strategy to eliminate these diseases as serious public health problems and prevent nearly 90,000 deaths by 2030.

Published
29 March 2017
From
National Academies of Science. Technology and Engineering
Warning of hepatitis A outbreak among men who have sex with men in Europe

An outbreak of hepatitis A in Europe has affected 287 people in at least 13 countries, with large numbers of cases in the United Kingdom,

Published
29 March 2017
By
Keith Alcorn
The 2017 Hepatitis C Community Summit – a key step on the road to elimination

In the lead-up to the annual International Liver Congress (ILC) in Amsterdam, Eberhard Schatz of the Correlation Network writes about the Hepatitis C Community Summit that will be held in Amsterdam on the 18-19th of April to focus on community-related initiatives and their key role in the hepatitis C elimination movement. Read more about the Summit and register here.

Published
27 March 2017
From
BMC Blogs Network (blog)
Gilead hepatitis C drug patent faces European challenge

International groups representing doctors and patients have launched a fresh challenge to the patent on Gilead Sciences' hepatitis C drug sofosbuvir at the European Patent Office in order to increase access to the treatment.

Published
27 March 2017
From
Reuters

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.